Pitney Bowes (PBI) Cash & Equivalents (2009 - 2026)

Pitney Bowes (PBI) has 18 years of Cash & Equivalents data on file, last reported at $302.9 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $302.9 million, down 6.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $302.9 million (down 6.46% YoY), and the FY2025 annual result was $284.9 million, down 39.35% from the prior year.
• Cash & Equivalents grew to $302.9 million in Q1 2026 per PBI's latest filing, from $284.9 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $668.3 million in Q4 2022 and troughed at $284.9 million in Q4 2025.
• A 5-year average of $489.7 million and a median of $541.7 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents increased 8.94% in 2024, then tumbled 51.68% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $668.3 million in 2022, then declined by 10.22% to $600.1 million in 2023, then retreated by 21.72% to $469.7 million in 2024, then tumbled by 39.35% to $284.9 million in 2025, then rose by 6.31% to $302.9 million in 2026.
• Business Quant data shows PBI's Cash & Equivalents at $302.9 million in Q1 2026, $284.9 million in Q4 2025, and $321.0 million in Q3 2025.